Corporate Profile
KALA BIO is a clinical-stage biopharmaceutical company on a mission. Guided by advanced science and an ever-climbing optimism, we’re focused on solving rare and serious eye diseases through research and development of innovative therapies. KALA BIO is a leader in the emerging field of mesenchymal stem cell secretome (MSC-S) therapy. Using our proprietary MSC-S platform, we are developing therapies with regenerative healing effects for rare ocular surface and retinal diseases, with the ultimate goal of preserving vision and changing lives.
Stock Quote
Minimum 15 minutes delayed. Source: LSEG
Latest Press Releases
Latest Events & Presentations
Dec 4, 2024 11:30 AM EST
Aug 15, 2024 7:00 AM EDT
Jun 5, 2024 12:30 PM EDT